Published in Law and Health Weekly, July 16th, 2005
This agreement combines Accium's expertise in AMS-based study design and in-house analytical services with Radiant's state-of-the-art clinical trials facilities to provide pharmaceutical researchers with comprehensive phase 0 (microdosing) and low radiation phase I clinical services nationwide.
"For the first time, this partnership provides our pharmaceutical sponsors with a one-stop solution for both the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly